Advice

in the absence of a submission from the holder of the marketing authorisation:

anakinra (Kineret®) is not recommended for use within NHSScotland.

Indication under review: Treatment of Familial Mediterranean Fever (FMF). Kineret should be given in combination with colchicine, if appropriate.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Download detailed advice616KB (PDF)

Download

Medicine details

Medicine name:
anakinra (Kineret)
SMC ID:
SMC2449
Indication:

Treatment of Familial Mediterranean Fever (FMF). Kineret should be given in combination with colchicine, if appropriate.

Pharmaceutical company
Swedish Orphan Biovitrum
BNF chapter
Musculoskeletal and joint diseases
Submission type
Non submission
Date advice published
13 December 2021